Investor Presentation
Mangalam Drugs & Organics Ltd has informed BSE regarding "Investor Presentation" May 2016.24-05-2016
24-05-2016
Standalone Financial Results, Form A, Auditors Report for March 31, 2016
Mangalam Drugs & Organics Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 20162. Standalone Form A for the period ended March 31, 20163. Standalone Auditors Report for the period ended March 31, 201616-05-2016
Outcome of Board Meeting
Mangalam Drugs & Organics Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 16, 2016, inter alia, has transacted the following business :1. Appointment of Ms. Anuradha Sukhani as Additional Director on the Board of the Company with effect from May 16, 2016. She will be Non executive - Independent Director of the Company....16-05-2016
Board Intimation for Results & Closure of Trading Window
Mangalam Drugs & Organics Ltd has informed BSE that the meeting of the Board of Directors of the Company will be held May 16, 2016, inter alia, to consider and approve the following:- To approve, consider and take on record the Audited Financial Results of the Company for the quarter and year ended March 31, 2016.Further, in accordance with Code of Conduct for Prevention of Insider Trading framed by the Company pursuant to the Securities...06-05-2016
Shareholding for the Period Ended March 31, 2016
Mangalam Drugs & Organics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly Click here15-04-2016
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016
Mangalam Drugs & Organics Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.13-04-2016
Outcome of Independent Directors Meeting
Mangalam Drugs & Organics Ltd has informed BSE that The Independent Directors at their seperate Meeting held on March 30, 2016 at the registered office of the Company, inter-alia transacted the following business:1. Reviewed the performance of non-independent directors and the Board as a Whole;.2. Reviewed the performance of the Chairperson of the Company, taking into account the views of executive directors and non-executive directors....30-03-2016
Independent Directors Meeting on March 30, 2016
Mangalam Drugs & Organics Ltd has informed BSE that a Meeting of the Independent Directors of the Company, is proposed to be held on March 30, 2016, inter alia, to transact the following business;1. To review the performance of non-independent directors and the board of directors as a whole;2. Review the performance of the chairperson of the listed entity, taking into account the views of executive directors and non-executive directors;...25-03-2016
Shareholding for the Period Ended December 31, 2015
Mangalam Drugs & Organics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2015. For more details, kindly Click here18-03-2016